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enough in most cases as oncoplastic technique for breast
cancer even with central or periareolar localization’’ q(1) Thirteen cases with N0 have been operated by a complete
axillary dissection. Would it be better to undertake sentinel
lymph node biopsy (SLNB) in these cases?
Answer: Our treatment guidelines do not include SLNB,
although it is very much acceptable, but our breast cancer pa-
tients are not candidates for such technique. However, previ-
ous studies at NCI found an incidence of LN metastasis in
T1 tumors of about 70%.
(2) The patients with periareolar tumor localization (half of
the patients) underwent needlessly a pedicled ﬂap opera-
tion instead of an advancement ﬂap or simple rotation ﬂap.
They are simple and therefore less time-consuming onco-
plastic procedures. They do not require whole nipple–are-
ola complex. Therefore, advancement ﬂaps or periareolar
mastopexy (1) was more reasonable.
Answer: We believe that the proposed technique (advance-
ment ﬂaps) will result in nipple areola complex shift and bad
cosmetic outcome, that is why our described technique,
although the number of cases is limited, will allow for central-
ization of the NAC and better cosmesis.
(3) Ten patients with N2 represent locally advanced cancer of
breast (Stage III). They should be treated primarily by sys-
temic therapy instead of surgery ﬁrst. It needs
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vanced disease, or nodal disease would receive CT primarily
N2 regarding the number of lymph nodes.
(4) Four cases with N+ have not been given adjuvant
chemotherapy. It should be explained.
Answer: They refused to receive CT.
(5) The rates of good cosmetic results were the same for both
patients and doctors. But in the literature, the rates of
health professionals are nearly always lower than patients
(2). It needs explanation.
Answer: We do not think it needs explanation. This is a
subjective way for analysis of cosmetic appearance. Moreover,
according to the literature, patient expectations usually lead to
a lower acceptance than surgeons.
(6) The condition of contralateral breasts has not been
presented. Is not there some cases requiring contralateral
mastoplasty, reduction or any other cosmetic procedure?
Answer: Yes, some of them needed contralateral
symmetrization which was performed after the end of the
study, but these complementary procedures were not in-
cluded in the study. On the other hand, other patients re-
fused this symmetrization procedure.
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